Company Active LTD

Company profile

Evergreen Health Solutions Ltd

askmyGP

Evergreen Health Solutions Ltd is a UK company with status active founded in 2015.

CRN
09484935
Founded
2015
Age
11

Overview

Legal name
EVERGREEN HEALTH SOLUTIONS LTD
Region
Unknown
Registered address
EVERGREEN HOUSE THE EDGE
CLOWES STREET
MANCHESTER
UNITED KINGDOM
M3 5NA
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Evergreen Health Solutions Ltd
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

10 events
31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

20 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

06 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun
2025

Accounts filed

Accounts

Last accounts made up date

20 Feb
2025

Accounts With Accounts Type Group

Accounts PDF pending

AA | Transaction MzQ1NTcwMzA1NWFkaXF6a2N4 | Paper/PDF filed

Published 21 Feb 2025 07:09

20 Feb
2025

Second Filing Of Director Appointment With Name

Officers

RP04AP01 | Transaction MzQ1NTY2OTIwMWFkaXF6a2N4

Published 20 Feb 2025 08:18

22 Oct
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0MDM3NzgxOGFkaXF6a2N4

Published 21 Oct 2024 11:31

13 Aug
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzMTkxMTg0N2FkaXF6a2N4

Published 13 Aug 2024 00:32

16 Mar
2015

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzExOTI1MDQxMmFkaXF6a2N4 | Paper/PDF filed

Published 21 Feb 2025 08:45

12 Mar
2015

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2023
Age at first award
7 years

Projects

2023 Collaborative R&D Lead participant

Using NLP to Target Patient Led and Scalable Primary Care Interactions

1 Apr 2023 to 31 Mar 2026

Awarded
£439,521
Total cost £627,887

Collapsing morale among general practitioners (GPs), a shrinking GP workforce, relentless demands, and increasing workload have caused many to sound alarm on a general practice in "crisis" \[1\]. Online Consultation (OC) systems are part of the solution. They help GPs to manage patient requests and workload more effectively while allowing patients to cont...

2022 Collaborative R&D Lead participant

Predicting kidney and liver damage in cancer patients receiving chemotherapy

1 Aug 2022 to 31 Jul 2024

Awarded
£268,190
Total cost £383,129

Chemotherapy is the treatment of disease using chemical substances, commonly used to treat cancer. Chemotherapy is often cytotoxic and two common risks relate to kidney and liver damage. Affected patients may require delays or changes to treatment and even treatment suspension. Whilst only <10% of patients will encounter kidney and or liver damage, curren...

Product types

Collaborative R&D